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DELIVERY SYSTEM FOR A COMPOSITION 
This application is a continuation of US. patent applica 
tion Ser. No. 11/128,443 ?led on May 13, 2005, Which 
claims the bene?t of Provisional Patent Application Ser. No. 
60/570,927 ?led on May 13, 2004, the disclosures ofeach of 
Which are incorporated herein in their entirety by reference. 
TECHNICAL FIELD 
The present invention relates to devices and methods for 
cutaneous delivery of a composition. Speci?cally, the inven 
tion relates to devices and methods for cutaneous delivery of 
a composition using ordered nanoporous membranes com 
prising aligned nanotubules embedded in a polymer matrix. 
The membranes of the present invention can be functional 
iZed for selective transport of the composition. 
BACKGROUND OF THE INVENTION 
Cutaneous patches, such as transdermal patches, are 
popular methods of non-invasive controlled release drug 
delivery. Additional uses of patch technology include appe 
tite stimulation and/or suppression, for Weight increase/ 
maintenance or control. Advantages of transdermal delivery 
include avoidance of gastrointestinal side-effects, avoidance 
of the hepatic ?rst-pass e?fect, maintenance of therapeutic 
drug levels for up to one Week, reduction of drug peak 
related side effects, improved patient compliance, and easy 
termination of drug input. Example transdermal drug deliv 
ery systems are currently available for nicotine (over the 
counter formulations by various manufacturers), clonidine 
(for example, CATAPRES), and fentanyl (for example, 
DURAGESIC). 
Currently available transdermal delivery systems are 
effective for their intended purposes, but Would bene?t from 
improvements. For example, it is knoWn that nicotine 
replacement smoking cessation therapy is improved by 
delivering nicotine at a similar rate as Would be derived by 
smoking a cigarette, Which results in peaks in plasma 
nicotine and improved satisfaction of cravings (BenoWitZ et 
al., Sources of variability in nicotine and cotinine levels With 
use of nicotine nasal spray, transdermal nicotine, and ciga 
rette smoking, Brit. J. ofClin. Pharm. (1997) 43, 259-267; 
Russell, Nicotine replacement: the role of blood nicotine 
levels, their rate of change, and nicotine tolerance, In: 
Pomerleau et al., eds., Nicotine replacement: a critical 
evaluation, NeW York: Alan R. Liss, 1988, 187-217). HoW 
ever, conventional nicotine patches deliver nicotine at a 
constant rate resulting in steady plasma nicotine levels, and 
are therefore less effective (Gourlay et al., Double blind trial 
of repeated treatment With transdermal nicotine for relapsed 
smokers, BMJ (1995) 311, 363-6). 
As another example, use of clonidine during opiate With 
draWal therapy often requires an extremely complex dosing 
regimen. Current transdermal patch technologies cannot 
easily be adapted to such dosing regimens, and accordingly 
oral clonidine therapy is much more common. Delivery of 
clonidine therapy via a transdermal delivery system capable 
of providing a complicated, staggered dosage regimen 
Would alloW less medical supervision, decreasing health 
care costs. Still further, a programmable transdermal deliv 
ery system Would alloW ?exibility in delivery and With 
draWal rates for the drug, alloWing ?exibility in dose titra 
tion during delivery and also during WithdraWal from the 
drug, reducing the rebound effects associated With clonidine 
Withdrawal. 
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The present invention addresses the identi?ed need in the 
art by providing a cutaneous delivery system for a compo 
sition, comprising an ordered nanoporous membrane and a 
reservoir in ?uid communication With the membrane. The 
nanoporous membrane of the present invention can be 
functionaliZed in a variety of Ways at the pore openings to 
impart selectivity to the membrane, to provide a selectively 
gateable membrane as Well as other functions. A cutaneous 
delivery device for a composition is provided also. In one 
embodiment, the cutaneous delivery device is adapted to 
deliver the composition selectively in response to an elec 
trical impulse. 
SUMMARY OF THE INVENTION 
In accordance With the purposes of the present invention 
as described herein, a device is provided for cutaneous 
delivery of a composition, comprising an ordered nanopo 
rous membrane including a plurality of aligned holloW 
nanotubules and a reservoir in ?uid communication With the 
ordered nanoporous membrane. The reservoir may be any 
suitable structure used as a reservoir, such as a receptacle 
containing the composition, a porous matrix releasably 
impregnated With the composition, or the like. It Will be 
appreciated also that the composition may be provided in a 
variety of physical forms, including but not limited to a 
liquid, a gel, or any other suitable physical form. The device 
may further include a supplemental membrane, Wherein the 
ordered nanoporous membrane is interposed betWeen the 
reservoir and the supplemental membrane. The supplemen 
tal membrane may include, or be in contiguous contact With, 
a suitable adhesive for adhering the device to a surface such 
as skin. 
The ordered nanoporous membrane may be formed by 
aligning the plurality of holloW nanotubules, coating the 
aligned holloW nanotubules With a continuous polymer 
matrix to form a membrane, and etching the membrane to 
open the plurality of holloW nanotubules and form pores. 
The etching step may also oxidiZe an end of the nanotubules 
to form carboxylate groups. In one embodiment, the ordered 
nanoporous membrane may be selectively etched to shorten 
the plurality of nanotubules to a length that is less than a 
dimension of the polymer matrix, thereby improving ?ux by 
reducing the distance traveled by the composition. Typically, 
the ordered nanoporous membrane is selectively etched by 
electrochemical oxidation, although it Will be appreciated 
that any suitable etching technique may be utiliZed, With the 
proviso that the nanotubules are selectively shortened to a 
greater degree than the polymer matrix. 
The ordered nanoporous membrane typically also 
includes at least one additional functional unit bound adja 
cent the nanotubule pore, Which may selectively expose or 
at least partially occlude the pore. The additional functional 
unit may include at least one available amine group for 
binding to the nanotubule end carboxylate group. The at 
least one additional functional group may be selected from 
the group consisting of a ligand, a receptor, a receptor-ligand 
complex, a reversibly binding receptor-ligand complex, a 
charged molecule, a binder-ligand complex, a reversibly 
binding binder-ligand complex, a ligand adapted for spe 
ci?cally binding to a predetermined target molecule, a 
hydrophilic molecule, a hydrophobic molecule, a catalytic 
coordination compound, a catalytic metal, biotin, avidin, 
streptavidin, aliphatic amines, charged dyes, anionically 
charged ligands, cationically charged ligands, or any com 
bination. 
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In one embodiment, the additional functional unit 
includes a charged group, and selectively exposes or at least 
partially occludes the pore of an adjacent nanotubule in 
response to an electrical impulse. In this embodiment, the 
nanotubules are typically electrically conducting and the 
continuous polymer matrix is typically electrically insulat 
ing, Whereby the effect of the electrical impulse is substan 
tially restricted to the plurality of nanotubules. The device 
may further include at least one contact in electrical com 
munication With the ordered nanoporous membrane, and an 
actuator in electrical communication With the at least one 
contact. It Will be appreciated that the actuator may be as 
simple as a sWitch for delivering an electrical impulse, or 
may be a programmable actuator such as a microchip, to 
alloW initiation and termination of the electrical impulse at 
predetermined intervals. 
In this embodiment, the additional functional unit may be 
selected from the group of charged groups consisting of 
acetate, aluminate, amino sulfonate, ammonium, quaternary 
ammonium, arsenate, aZide, carbonate, borate, bromate, 
bromite, carbide, chlorite, chromate, chromite, cyanate, 
dichromate, phosphate, phosphite, disul?de, formate, fulmi 
nate, sulfate, sul?de, hydrogen sul?te, hydroxide, nitrate, 
nitrite, oxalate, pyridinium, pyrophosphate, sul?te, sulfo 
nium, tartrate, thiocyanate, thiosulfate, toluenesulfonate, 
charged metal coordination compounds, or any combination 
thereof in accordance With the desired function. The nano 
tubules may be selected from the group consisting of multi 
Walled carbon nanotubes, single-Walled carbon nanotubes, 
self-assembling macromolecular tubules comprising pep 
tides and porphyrins, or any combination thereof. 
In another aspect of the present invention, a method for 
cutaneous delivery of a composition is provided, comprising 
providing a reservoir containing the composition in ?uid 
communication With an ordered nanoporous membrane 
comprising a plurality of holloW nanotubules and passing 
the composition through the ordered nanoporous membrane. 
As described above, the ordered nanoporous membrane may 
be formed by aligning the plurality of holloW nanotubules, 
coating the aligned holloW nanotubules With a continuous 
polymer matrix to form a membrane, and etching the mem 
brane to open the plurality of holloW nanotubules and form 
pores. The etching step may further oxidiZe an end of the 
nanotubules to form carboxylate groups. The membrane 
may further be selectively etched to shorten the plurality of 
nanotubules to a length that is less than a dimension of the 
polymer matrix. Any suitable method for etching the mem 
brane may be selected, including but not limited to electro 
chemical oxidation, With the proviso that the membrane is 
selectively etched Whereby the nanotubules are shortened as 
noted above. 
The method may further include the step of binding an 
additional functional unit adjacent the nanotubule pore. The 
additional functional unit may selectively expose or at least 
partially occlude the pore. Typically, functional units includ 
ing an available amine group to bind to the nanotubule end 
carboxylate group are selected. The at least one additional 
functional group may be selected from the group consisting 
of a ligand, a receptor, a receptor-ligand complex, a revers 
ibly binding receptor-ligand complex, a charged molecule, a 
binder-ligand complex, a reversibly binding binder-ligand 
complex, a ligand adapted for speci?cally binding to a 
predetermined target molecule, a hydrophilic molecule, a 
hydrophobic molecule, a catalytic coordination compound, a 
catalytic metal, biotin, avidin, streptavidin, aliphatic amines, 
charged dyes, anionically charged ligands, cationically 
charged ligands, and any combination thereof. 
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In one embodiment, the additional functional unit may 
include a charged group, and selectively exposes or at least 
partially occludes the pore of an adjacent nanotubule in 
response to an electrical impulse. In that embodiment, the 
nanotubule is typically electrically conductive, and the poly 
mer matrix is typically electrically insulating. The additional 
functional unit may be selected from the group consisting of 
acetate, aluminate, amino sulfonate, ammonium, quaternary 
ammonium, arsenate, aZide, carbonate, borate, bromate, 
bromite, carbide, chlorite, chromate, chromite, cyanate, 
dichromate, phosphate, phosphite, disul?de, formate, fulmi 
nate, sulfate, sul?de, hydrogen sul?te, hydroxide, nitrate, 
nitrite, oxalate, pyridinium, pyrophosphate, sul?te, sulfo 
nium, tartrate, thiocyanate, thiosulfate, toluenesulfonate, 
charged metal coordination compounds, or combinations 
thereof. 
The method may further include the step of providing at 
least one contact in electrical communication With the 
ordered nanoporous membrane. An actuator in electrical 
communication With the at least one contact may also be 
provided. As noted above, the actuator may be as simple as 
an on-olf sWitch, or may be a programmable system such as 
a microchip controlling a poWer source. 
It should be appreciated that the embodiments shoWn and 
described herein are an illustration of one of the modes best 
suited to carry out the invention. It Will be realiZed that the 
invention is capable of other different embodiments and its 
several details are capable of modi?cation in various, obvi 
ous aspects all Without departing from the invention. 
Accordingly, the draWings and descriptions Will be regarded 
as illustrative in nature, and not as restrictive. 
BRIEF DESCRIPTION OF THE DRAWINGS 
The accompanying draWings incorporated in and forming 
a part of the speci?cation, illustrate several aspects of the 
present invention and together With the description serve to 
explain the principles of the invention. In the draWings: 
FIG. 1 shoWs ?ux of nicotine through the ordered nano 
tubule membrane of the present invention as a function of 
nanotubule tip functionaliZation; 
FIG. 2 shoWs ?ux of nicotine through a polymer mem 
brane/ skin composite With and Without the ordered nanotu 
bule membrane of the present invention; 
FIG. 3 schematically depicts the opening and closing of 
nanotubule pores by a charged functional group (amino 
sulfonate) using application of a positive or a negative bias; 
FIG. 4 schematically depicts a tether molecule comprising 
a series of polypeptide links, Wherein length is controlled by 
successive carboimide reactions at a nanotubule (n) pore; 
FIG. 5 shoWs transport of methylviologen2+ across a 
nanotubule membrane functionaliZed With anionic dye 
coupled to a tether molecule (see FIG. 4) consisting of 2 
polypeptide links; 
FIG. 6 schematically depicts an embodiment of a cuta 
neous delivery system, Wherein delivery of a composition is 
effected by application of an electrical impulse; and 
FIG. 7 schematically depicts various molecules useful in 
functionaliZing the ordered nanoporous membrane of the 
present invention With charged molecules: (711) long chain 
amino sulfonate; (7b) short chain amino sulfonate; (7c) 
schematic depiction of a charged triphenylphosphonium 
molecule having added chain lengths; (7d) schematic depic 
tion of attachment of a charged thiol-gold nanocrystal mol 
ecule. 
US 7,229,556 B1 
5 
Reference will now be made in detail to the present 
preferred embodiment of the invention, an example of which 
is illustrated in the accompanying drawings. 
DETAILED DESCRIPTION OF THE 
INVENTION 
The following examples are presented in support of and to 
further illustrate the invention as described herein. However, 
the invention is not to be considered as limited thereto. The 
patents, patent applications, and citations of literature 
referred to herein are understood to form a part of this 
disclosure, and are incorporated in their entirety by refer 
ence. 
EXAMPLE 1 
Ordered nanoporous membranes were prepared substan 
tially as described in US. patent application Ser. No. 11/ 128, 
443, ?led on May 13, 2004. Aligned carbon nanotubes 
(CNTs) were grown in situ using substantially the methods 
described in R. Andrews et al., Continuous production of 
aligned carbon nanotubes: a step closer to commercial 
realiZation, Chem. Phys. Le”. (1999) 303, 467-474, on 
quartz substrate using a ferrocene-xylene-argon-hydrogen 
feed in a chemical vapor deposition process. A 50 weight 
percent solution of polystyrene (PS) and toluene was spin 
coated over the surface to impregnate the CNT array. The 
?lm was dried in vacuum for 4 days, and hydro?uoric acid 
was then used to remove the CNT-PS composite from the 
quartz substrate, to produce a freestanding composite ?lm of 
5 to 10 um thickness. 
A thin layer of excess polymer from the top surface was 
then removed to open the CNT tips and form the pores of a 
membrane structure. This was accomplished with H2O 
plasma-enhanced oxidation process at conditions similar to 
conditions used to remove Fe nanocrystal catalyst particles 
from the CNT tips. The plasma oxidation process etched PS 
faster than CNTs; thus, the CNT tips were 10 to 50 nm above 
the polymer surface. The plasma oxidation process also left 
the tips of the CNTs functionaliZed with carboxylate groups, 
ready to react with amine-terminated biomolecules as will 
be discussed below. 
The physical, chemical, and biomolecule transporting 
properties of the membranes are described in greater detail 
in US. patent application Ser. No. 11/ 128,443. As described 
therein, the membrane nanotubule tips of this invention can 
be functionaliZed with a variety of additional functional 
groups. Transport of nicotine through membranes containing 
non-functionaliZed CNT tips was compared to membranes 
having CNT tips functionaliZed with long chain alkanes. To 
functionaliZe the CNT membranes with long chain alkanes, 
the following conditions were used: 95.75 mg of EDC 
(1 -ethyl-3 -(3-dimethylaminopropyl) carbodiimide hydro 
chloride), 195.24 mg 2-(N-morpholino)ethane sulfonic acid 
(MES) buffer (pH 6.5), and 13.48 mg of octadecyl amine 
were weighed and added to 10 cc of water to make a solution 
having 50 mM EDC, 0.1 M MES, and 5 mM octadecyl 
amine. The solution was ultrasonicated for 10-15 minutes. 
Next, the membrane was immersed in the solution for 4 
hours. 
The CNT membrane was placed in a u-cell separating 10 
mg/ml of nicotine in pH 7.4 buffer solution from buffered 
analyte solution. The concentration of nicotine in the analyte 
solution as a function of time was quanti?ed by HPLC with 
UV detection. Analytical samples were prepared by diluting 
250 pl of diffusion or standard samples in isotonic phosphate 
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buffer pH 7.4 to 1 mL with acetonitrile. Samples were 
centrifuged at 3500><g for 5 min, and the supernatant was 
analyZed by reversed-phase HPLC (Perkin-Elmer Series 200 
pump, autosampler, Brownlee Spheri5 VL C18 5 pm column 
with RP-18 7 pm guard column, 785A UV/VIS detector set 
at 259 nm, and Turbochrom 6.1.2 software). The mobile 
phase was acetonitrile and pH 5.5 acetate buffer (70:30). The 
acetate buffer was 0.05 M sodium acetate anyhydrous and 
0.25% triethylamine. Flow rate was 1 ml/minute, and injec 
tion volume was 20 pl. 
As shown in FIG. 1, a ?ux of 17 p.mol/cm2~hr was 
achieved using a membrane having non-functionaliZed CNT 
tips, which compares favorably with conventional transder 
mal patch delivery rates of 2-6 umol/hr for steady state 
delivery with increased rate requirements up to 20 umol/hr 
for desired peaks in drug levels that simulate smoking. 
Typical transdermal patches are 5-25 cm2 in siZe, resulting 
in a ?exible required nicotine ?ux rate range of 0.08-4 
umol/cm2~hr. This is well below published literature values 
for nicotine ?ux in human skin, as rates as high as 8.3 
umol/cm2~hr have been reported from 50% nicotine solu 
tions in water [Zorin et al., In vitro test of nicotine’s 
permeability through human skin. Risk evaluation and 
safety aspects, Ann. Occup. Hyg. 43 (1999) 405-413]. 
Accordingly, skin is not expected to be the rate-limiting step 
to transport of a composition in the present invention, but 
rather the ordered nanoporous membrane is expected to 
control the input rate. 
Referring again to FIG. 1, it was shown that ?ux rate of 
nicotine through the membrane could be controllably 
reduced using long chain alkanes. FunctionaliZation of the 
CNT tips with octadecyl amine reduced the ?ux rate to 2.7 
umol/cm2~hr, or a factor of 6.2. Since the long chain amine 
was 2.4 nm in length, the resultant CNT pore diameter was 
expected to be 2.7 nm (7.5 nm—4.8 nm). The CNT cross 
section surface area was reduced by a factor of 7.5, which 
was very close to the experimentally observed ?ux reduc 
tion. 
It will be appreciated, as discussed and described in 
greater detail in US. patent application Ser. No. 11/128,443, 
that the foregoing synthesis conditions are applicable to a 
variety of functional molecules, with the proviso that the 
molecule is amine-terminated to allow binding to the nano 
tubule carboxylate group. Accordingly, longer or shorter 
chain molecules may be provided to increase or decrease 
?ux rate as desired, by occluding the nanotubule pores to a 
greater or lesser degree in accordance with the properties of 
the composition to be transferred, such as molecular siZe. As 
described in US. patent application Ser. No. 11/ 128,443, the 
ordered nanoporous membrane may be selectively etched, 
such as by electrochemical oxidation, to reduce the length of 
the nanotubules to a greater degree than the width of the 
polymer matrix, thereby shortening the diffusion path and 
increasing ?ux rate, without compromising membrane 
strength or integrity. 
It is common in the art to deliver certain compositions, 
such as drugs, via a cutaneous patch. Such patches have been 
found desirable for their convenience and ease of use. As 
examples, three skin-permeable drugs often delivered by 
cutaneous patch are nicotine (used in smoking cessation), 
fentanyl (used in pain management), and clonidine (used in 
opiate withdrawal and management of hypertension). The 
molecular weight range for nicotine, fentanyl, and clonidine 
is 162-336, with nicotine being the smallest and fentanyl the 
largest. The drugs range in lipophilicity from log octanol/ 
water partition coef?cient values of 0.88-3.62, with nicotine 
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being the most polar and fentanyl the least. It is known that 
nicotine and fentanyl require fast input rates to achieve 
peaks in drug levels. 
Conventional nicotine patches deliver 0.33 to 1 mg of 
nicotine per hour, meaning that the target for constant rate 
baseline delivery is 2-6 pmol/hr. A commercially marketed 
nicotine spray delivers 1 mg of drug per dose, Which has a 
53% bioavailability. Accordingly, a dose of 530 pg (3.3 
pmol) must be delivered Within a short time frame. Selecting 
a delivery period of 10 min as an example, the fast delivery 
rate for peak nicotine levels Would be about 20 pmol/hr, 
Which as seen from the foregoing disclosure is easily 
attained by the ordered nanoporous membrane of the present 
invention. Conventional nicotine transdermal patches are 
5-25 cm2 in siZe, resulting in a ?exible required nicotine ?ux 
rate range of 0.08-4 pmol/cm2~hr. Skin is unlikely to be a 
rate-limiting factor, as ?ux rates as high as 8.3 pmol/cm2 hr 
have been reported from 50% nicotine solutions in Water 
(Zorin et al., 1999). Accordingly, the ordered nanoporous 
membrane of the present invention can be expected to 
reliably control the nicotine drug input rate to the body. 
An example dynamic dosing regimen for oral clonidine 
during opiate WithdraWal therapy is: 0.1 mg tWice daily on 
day 1, thrice daily on day 2, and four times daily on days 3 
and 4, thrice daily on days 5 and 6, tWice daily on days 7 and 
8, and once daily on days 9 and 10. The oral bioavailability 
of clonidine is 90% or less (decreased bioavailability With 
multiple dosing), so the required transdermal regimen can be 
expected to be 0.18 mg/d on day one, to a maximum rate of 
0.36 mg/d, and then doWn to 0.09 mg/d by the end of the 
treatment period [Frisk-Holmberg et al., Clonidine kinetics 
in man-evidence for dose dependency and changed pharrna 
cokinetics during chronic therapy, Brit. J. Clin. Pharm. 12 
(1981) 653-658]. A currently marketed loWest dose cloni 
dine patch delivers 4.32 pg/h from a 3.5 cm2 patch, or 1.2 
pg/cm2~hr [Toon et al., Rate and extent of absorption of 
clonidine from a transdermal therapeutic system, J. Pharm. 
and Pharmacol. 41 (1989) 17-21]. Flux values for clonidine 
in human skin are reported as high as 3.3 pg/cm2~hr [Wang 
et al., Permeation studies of clonidine through skins and 
different arti?cial membranes, Zhongua Yaoxue Zazhi 45 
(1993) 591-600]. Assuming a 10 cm2 patch, the required 
delivery rate range for a transdermal patch Would be 0.375 
to 1.5 pg/cm2~hr to ensure that the skin Would not rate-limit 
the drug delivery. Again, this delivery rate is Well Within the 
delivery rate ranges achievable using the nanoporous 
ordered membrane of the present invention. 
As another example, commercially available fentanyl 
patches used in pain management deliver constant rates of 
25 to 100 pg/hr. The lag time across human skin is 12 
minutes, Which is important for the breakthrough pain 
treatment increase in delivery rates [Roy et al., Transderrnal 
delivery of narcotic analgesics: pH, anatomical, and subject 
in?uences on cutaneous permeability of fentanyl and sufen 
tanil, Pharm. Res. 7 (1990) 842-847]. Breakthrough cancer 
pain can be treated With a fentanyl nasal spray at a dose of 
20 pg, Which results in analgesia Within 10 minutes [Zep 
petella, G., An assessment of the safety, e?icacy, and accept 
ability of intranasal fentanyl citrate in the management of 
cancer-related breakthrough pain: a pilot study, J. Pain and 
Symptom Management 20 (2000) 253-258]. Breakthrough 
cancer pain is often treated With a 200 pg fentanyl loZenge 
(ACTIQ®) in patients already under treatment With opioids. 
The buccal bioavailability of this fentanyl loZenge is 50%, 
so the delivery of 100 pg over 10 minutes Would be a 
reasonable transdermal delivery goal for pain bouts (0.6 
mg/cm2~hr). Maximum ?ux rates of fentanyl across human 
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skin have been reported at 2.6 mg/cm2~hr [Roy et al., 1990; 
Michaels et al., AlChE 21 (1975) 985-996]. 
The ordered nanoporous membrane of the present inven 
tion Was shoWn to provide a delivery rate for a composition 
Well Within the necessary ranges for such compositions as 
nicotine, clonidine, and fentanyl in accordance With infor 
mation derived from delivery rates of conventional cutane 
ous patches. Attention Was therefore turned to adapting the 
ordered nanoporous membrane for use as a component of a 
cutaneous patch. 
EXAMPLE 2 
Consideration Was given to supplemental membranes for 
use as components of cutaneous delivery systems in com 
bination With the ordered nanoporous membranes of the 
present invention. Potentially suitable polymer ?lms and 
pressure sensitive adhesives Were evaluated to de?ne poly 
mer/adhesive combinations providing the least di?‘usional 
resistance. Four commercially-available polymer mem 
branes and three pressure sensitive adhesives Were consid 
ered. The four membranes evaluated Were: (1) a copolyester 
membrane (MEDIFILM® 390; Mylan Technologies, Inc., 
St. Albans, VT); (2) a polyurethane membrane (MEDI 
FILM® 437); (3) an ethyl vinyl acetate membrane (MEDI 
FILM® 500); and (4) a polyether block amide membrane 
(MEDIFILM® 840). The adhesives evaluated Were: (1) an 
acrylic pressure sensitive adhesive having no functional 
groups to prevent chemical interaction of drugs With adhe 
sive polymer (DURO-TAK® 87-900A, National Starch & 
Chemical Co., BridgeWater, N.J.); a silicone pressure sen 
sitive amine-compatible adhesive (BIO-PSA® 7-4303, Dow 
Corning Co., Midland, Mich.); and (3) a silicone pressure 
sensitive standard adhesive (BlO-PSA® 7-4606, DoW Com 
ing). 
The adhesives Were adhered to the different polymer 
membranes, and the adhesive/polymer combination Was 
pressed onto pieces of hairless guinea pig skin. Skin samples 
Were also tested With the same drug solution Without adhe 
sive/polymer combinations. The membrane composites 
Were placed into ?oW-through PermeGear diffusion cells at 
320 C. (n:3), and nicotine in phosphate buffer Was applied 
to the polymer surface. Experiments Were run for a 24 hr 
period With a receiver solution of isotonic phosphate buffer 
solution pH 7.4 at a How rate of 5 mL/hr. Samples Were 
collected every 3 hr using a fraction collector. Nicotine 
concentration in collected samples Was determined by 
HPLC as described in Example 1. Results are presented in 
Table 1. 
TABLE 1 
Nicotine ?ux rates for combinations of polymer membranes and 
pressure sensitive adhesives. 
Polymer membrane/adhesive Flux rate (pInol/cm2.hr) 
MEDIFILM ® 840/DURO-TAK ® 19.3 r 2.9 
87-900A 
MEDIFILM ® 840/BIO-PSA ® 7-4303 9.7 r 2.2 
MEDIFILM ® SOO/BIO-PSA ® 7-4303 8.7 r 6.2 
MEDIFILM ® 390/BIO-PSA ® 7-4303 17.2 r 4.9 
MEDIFILM ® 437/BIO-PSA ® 7-4303 12.1 r 0.9 
MEDIFILM ® 437/BIO-PSA ® 7-4606 18.8 r 5.1 
Skin only 31.4 r 9.3 
These results indicated that the combinations of a poly 
ether block amide membrane/acrylic pressure sensitive 
adhesive Without functional groups, polyether block amide 
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membrane/silicone pressure sensitive amine-compatible 
adhesive, and polyurethane membrane/silicone pressure 
sensitive standard adhesive provided acceptable ?ux rates 
for nicotine. HoWever, it Was noted that all polymer mem 
branes evaluated provided ?ux rates for nicotine that Were 
Well in excess of the maximum required delivery rate of 4 
p.mol/cm2~hr as has been found desirable in a conventional 
nicotine cutaneous patch as previously discussed. Therefore, 
the supplemental polymer membranes are not expected to 
contribute appreciably to variation in ?ux rate. 
It Will be appreciated also by the skilled artisan that the 
selection of combinations of polymer membranes/ adhesives 
for use in a cutaneous delivery system Will be dictated by the 
properties of the compositions to be passed therethrough, 
i.e., by the desired ?ux rate for the particular compositions, 
the propensity of the composition to interact With the 
polymer and/or the adhesive, and the like. Such evaluations 
are Well Within the knowledge possessed by the skilled 
artisan. 
EXAMPLE 3 
Next, a delivery system adaptable for cutaneous delivery 
Was evaluated, comprising the ordered nanoporous mem 
brane of Example 1 as the rate-controlling component and 
the polymer/ adhesive supplemental membrane of Example 2 
as a protective mechanism to reduce risk of biofouling of the 
ordered nanoporous membrane. A non-functionaliZed CNT 
membrane prepared substantially as described in Example 1 
Was adhered to MEDIFILM® 840 using DURO-TAK® 
87-900A. The composite membrane Was placed into a 
?ow-through diffusion cell and evaluated for nicotine trans 
port as described in Example 2. Polymer/ skin patches (With 
out CNT membranes) Were used as controls. 
As shoWn in FIG. 2, the nicotine ?ux from the CNT 
membrane/polymer membrane/ skin patches Was 8-fold less 
than nicotine ?ux from the polymer membrane/ skin patches. 
A good linear steady-state diffusion pro?le Was obtained 
With the CNT membrane/polymer membrane/ skin patches 
over a 24 hr period, and the membrane Was intact and 
undamaged at the end of the experiment (not shoWn). 
Nicotine ?ux from the membrane Was 0.90 umol/cm2~hr, 
Well Within a desirable delivery range for nicotine of 008-4 
p.mol/cm2~hr. 
Accordingly, the present Work demonstrates that the 
ordered nanoporous membranes of this invention can be 
adapted as components of a patch for delivery of a compo 
sition to a surface such as skin. It Will be appreciated that, 
based on knoWn physicochemical properties of composi 
tions adaptable for delivery by a cutaneous patch, properties 
of the patches can be optimiZed for speci?c delivery rates of 
the drug of choice. In cases Where the ?ux value for a 
particular composition intended to be provided as a trans 
dermal formulation is less than desired for a predetermined 
transdermal delivery rate, penetration enhancers such as 
ethanol, oleic acid, or other surfactants may be added to the 
compositions to improve delivery rate. 
For complicated dosage regimens such as that described 
herein for clonidine, and also for intermittent dosage regi 
mens for drugs such as nicotine or fentanyl Wherein it is 
desired to provide drug delivery “peaks” interspersed With 
intervening periods of reduced or no drug delivery (to 
address intermittent events such as nicotine craving or 
breakthrough pain, for example), it is desirable to adapt a 
cutaneous delivery system as described in the foregoing 
disclosure for selective delivery of a composition, rather 
than constant delivery at a predetermined ?ux rate over time. 
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To address this need, a gateable ordered nanoporous mem 
brane is provided herein, Wherein the pores of the membrane 
can be selectively exposed or occluded. 
The nanotubules forming the membrane pores may be 
functionaliZed at the tip With charged functional groups. As 
has been previously described (U .S. patent application Ser. 
No. 11/128,443), in the embodiment of the ordered nanotu 
bule membrane of the present invention comprising aligned 
carbon nanotubes in a polymer matrix (Example 1), the 
carbon nanotubes are conductive, While the polymer matrix 
(in the described embodiment, polystyrene) may be insulat 
ing. It Will be appreciated that placing a charged functional 
group adjacent to the nanotubule pore (attached thereto by 
the same amide chemistry as previously described herein, 
see Example 1, or by any other suitable method) alloWs use 
of electrostatic capacitance to draW the charged group 
toWards the conductive nanotubule Wall or to repel the 
charged group therefrom, occluding or exposing the nano 
tubule pore as shoWn schematically in FIG. 3. Of course, the 
electrical impulse applied Will be either a negative bias or a 
positive bias, depending on Whether the charged functional 
group used is positively or negatively charged, to achieve 
the desired attraction or repulsion from the nanotubule Wall. 
Because the polymer matrix is insulating, the applied bias 
or electrical impulse Would be applied only to the nanotu 
bule. This provides the further bene?t of being able to isolate 
the applied electrical impulse to the pores of the ordered 
nanoporous membrane, rather than to the entirety of the 
membrane and/ or the surface to Which the composition is to 
be delivered. This phenomenon is often seen With conven 
tional non-invasive programmable drug delivery methods 
such as iontophoresis, electroporation, and the like, resulting 
in undesirable skin irritation and/or disruption of the skin 
barrier. 
EXAMPLE 4 
An ordered nanotubule membrane Was fabricated sub 
stantially as described in Example 1, for use in evaluation of 
use of charged molecules for selective exposing/occlusion of 
the pores of the membrane. Apolypeptide tether (see FIG. 4) 
Was used to bond charged dye molecules (Direct Blue 71; 
Aldrich) adjacent the nanotubule pores using the carboimide 
chemistry substantially as described herein and in US. 
patent application Ser. No. 11/128,443. Brie?y, dye Was 
added to a 4 ml solution of 0.1 M MES to make a 50 mM 
solution. Eight mg of 1-[3-(Dimethylamino)propyl]-3ethyl 
carbodiimide hydrochloride (EDC) Was dissolved in the 
solution, folloWed by immersion of the nanotubule mem 
brane therein. The reaction proceeded for 12 hr at ambient 
temperature, folloWed by Washing With MES buffer and 
isopropyl alcohol to remove excess reagents. 
Flux through the functionaliZed membrane Was evaluated 
using a U-tube permeation experiment substantially as 
described in Example 1. Liquids in the tWo chambers of the 
permeation set-up Were maintained at the same level to 
prevent pressure-induced transport. Methyl viologen dichlo 
ride hydrate (methylviologen2+; Aldrich) Was the probe 
molecule. The permeate Was periodically pipetted out, tested 
for presence of probe molecule by UV-vis spectroscopy (HP 
8543 Spectrophotometer), and then transferred back to the 
chamber. A peak detected at 260 mm Was used to quantify 
the amount of methylviologen2+. A calibration curve Was 
determined by ?tting non-linear (to account for the non 
linear deviation from Lambert-Beer’s LaW in higher con 
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centrations of analyte) curves to plots of absorbance vs. 
conceptration of the analyte in the range 5*10‘4 (M) to 
1*10 (M). 
As shown in FIG. 5, the ?ux of methylviologen2+ through 
the functionaliZed nanotubule membrane Was altered by 
application of an electrical impulse to the dye/polypeptide 
functionaliZed nanotubule membrane. A 60% increase in 
?ux Was observed from a bias of +50 mV to —30 mV (0.1 M 
KCl electrolye), clearly demonstrating that the applied bias 
modulated chemical ?ux through the membrane of the 
present invention. 
EXAMPLE 5 
Referring noW to FIG. 6, a selectively gateable delivery 
system 10 is depicted Wherein the nanotubule pore of the 
ordered nanoporous membrane is selectively exposed or at 
least partially occluded by application of an electrical 
impulse (applied bias) as described in Example 4. The 
delivery system 10, in this embodiment adapted for use as a 
cutaneous delivery system, comprises a supplemental poly 
mer membrane 12, a nanotubule membrane 14 (see Example 
1) adhered to the polymer membrane 12, a reservoir 16 for 
holding a composition for delivery to a skin surface 18, and 
a cover 20. Any suitable fastener or restraint for maintaining 
contact betWeen the delivery system 10 and an adjacent 
surface may also be provided, such as an adhesive, an elastic 
loop, ring, or band, fastening tape, a strap, a buckled strap, 
a tie, a band secured by hook and loop material, and the like. 
For example, the polymer membrane 12 may optionally 
include a pressure sensitive adhesive (see Example 2) on a 
margin thereof to maintain the delivery system 10 in contact 
With a surface such as skin. 
A ?rst contact 22 is placed in electrical communication 
With the nanotubule membrane 14, and a second contact 24 
is placed in electrical communication With the reservoir 16. 
An actuator 26 is provided also, in electrical communication 
With the ?rst and second contacts 22, 24 via leads 28, 30. 
The cover 20 may be fabricated of any suitable material 
providing the desired protective effect. Typically, the cover 
20 Will be fabricated of a breathable material, Which pre 
vents entry of Water but alloWs escape of Water vapor such 
as perspiration, to improve user comfort. The actuator 26 
may be as simple as a poWer source (not shoWn) having a 
sWitch for alloWing transmission of an electrical current to 
the nanotubule membrane 14, or may comprise more com 
plex control electronics. Suitable actuators by Which pro 
grammable activation/deactivation of the delivery system 
can be achieved are knoWn in the art. For example, the 
actuators described in US. Pat. Nos. 6,539,250 and 6,723, 
077, the disclosures of Which are incorporated herein in their 
entirety by reference, can be adapted for use in the present 
invention. As noted above, the nanotubules of the membrane 
are typically electrically conductive, Whereas the polymer 
matrix is typically electrically insulating. Accordingly, the 
delivery system alloWs isolation of the applied electrical 
impulse to the nanotubule array of the ordered nanoporous 
membrane, reducing the likelihood of skin irritation, dis 
ruption of the skin barrier, and other similar undesirable 
effects. 
The skilled artisan Will quickly appreciate that the cuta 
neous delivery system described herein can be easily modi 
?ed for optimal delivery of a variety of compositions, based 
on knoWn physicochemical properties of the composition to 
be delivered. Particular emphasis is placed on the role of 
ionic strength for aqueous solutions placed in the reservoir 
16. Alternatively, non-polar solvents commonly used in 
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transdermal systems can be used for delivery of the com 
positions, such as mineral oil, propylene glycol, and ethanol. 
Since the membrane of the present invention has a surface 
resistance of 0.32/Qcm, it is Well Within the knoWledge 
expected of the skilled artisan to determine the optimal ionic 
strength of the composition reference solution to ?nd a 
threshold concentration for ionic interference in an aqueous 
solution. 
The required bias to attract charged groups into the 
nanotubule pores for occlusion thereof can also be estimated 
from electrochemical studies of long-chained charged func 
tional group (1 -thioundecanecarboxylic acid) monolayers on 
gold electrodes [Krishna et al., Tethered bilayer membranes 
containing ionic reservoirs: The interfacial capacitance, 
Langmuir 17 (2001) 4858-4866]. lnterfacial capacitances 
have been experimentally measured at from 2.4 uF/cm2 to 
1.6 uF/cm2 for solutions of 1 to 1000 mM ionic strength 
(NaCl). For nanotubule membranes comprising vertically 
aligned carbon nanotubes (Example 1) having approxi 
mately 20 charged functional groups per carbon nanotube 
(1><10l2/cm2) the required bias is 67-100 mV, Which is Well 
Within practical limitations. 
The structure of the double charge layer is largely deter 
mined by Helmholtz capacitance and the Debye screening 
length. Mobile ions in solution can reach the interface and 
effectively screen the charge on the electrode from the 
charged functional group at the end of the tethered func 
tional molecule (2-3 nm long). The Debye screening length 
in solution is given by the formula: 
Where E, is the relative dielectric constant of solvent (E,~80 
for H2O), T?emperature in Kelvin, kfBoltZman constant, 
and CS is ionic concentration in solution. 
In vivo ionic strengths (0.15M) have a Debye length of 
0.8 nm, Which is shorter than the length of the tethered 
molecule, and therefore ionic interference can be expected to 
be a variable to be considered. For a 0.01M solution the 
Debye length is an acceptable 3 nm. Using a mineral oil 
solvent can be expected to reduce E, to approximately 3, and 
CS to approximately mM, and accordingly net Debye screen 
ing lengths Would be approximately 50 nm. This is Well 
beyond the length of the tethered molecule, and ionic 
screening Would not be expected to be a factor When using 
non-aqueous solvents currently used for transdermal 
cutanous patches. The Debye screening length is actually an 
upper limit of ionic interference, since studies With poly 
electrolyte brushes predict signi?cant contraction in 0.1 M 
ionic strength solutions under applied bias using a modi?ed 
Gouy-Chapman length model [Zhulina et al., Screening 
effects in a polyelectrolyte brush: Self-consistent-?eld 
theory, Macromolecules 33 (2000) 4945-4953]. By varying 
ionic strength and E, of the aqueous solution, the present 
invention can easily be tailored for use of aqueous solvents 
Without ionic interference. 
It Will be appreciated by the skilled artisan that the 
carboimide chemistry described in the foregoing disclosure 
can be used to attach a variety of charged functional mol 
ecules adjacent the nanotubule pores of the ordered nanopo 
rous membrane of the present invention, for use as “gate 
keeper” molecules in devices such as a cutaneous patch as 
described in Examples 4 and 5. Alternatively, as discussed 
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supra other suitable methods for binding functional mol 
ecules adjacent the nanotubule pores may be employed, such 
as electrochemical modi?cation. The proviso is that the 
molecule must be amino-terminated, and must have a 
charged moiety Which causes the molecule to selectively 
expose or at least partially occlude the adjacent pore in 
response to an applied bias. Examples include, but are not 
limited to, amino sulfonates, charged triphenylphospho 
nium, and thiol-gold nanocrystal molecules. Polypeptide 
tethers may be fabricated using carboimide chemistry to 
increase the length of the charged molecule/tether composite 
as desired. 
EXAMPLE 6 
An ordered nanoporous membrane is synthesiZed sub 
stantially as described in Example 1. A commercially avail 
able long chain amino sulfonate (FIG. 7a) is attached to a 
carboxylate group at a nanotubule pore by the depicted 
amino group using the carboimide chemistry described in 
Example 1. 
EXAMPLE 7 
An ordered nanoporous membrane is synthesiZed sub 
stantially as described in Example 1. A commercially avail 
able short chain amino sulfonate (FIG. 7b) is attached to a 
carboxylate group at a nanotubule pore by the depicted 
amino group using the carboimide chemistry described in 
Example 1. 
EXAMPLE 8 
An ordered nanoporous membrane is synthesiZed sub 
stantially as described in Example 1. Chain lengths are 
added to charged triphenylphosphonium by acidic deprotec 
tion of cyclic acetyl group and reaction With n-amino bromo 
alkane (FIG. 70), and the molecule is attached to a carboxy 
late group at a nanotubule pore by the depicted amino group 
using the carboimide chemistry described in Example 1. 
EXAMPLE 9 
An ordered nanoporous membrane is synthesiZed sub 
stantially as described in Example 1. A polypeptide tether 
(FIG. 4) is attached to a carboxylate group at a nanotubule 
pore by the depicted amino group using the carboimide 
chemistry described in Example 1. Length of the polypep 
tide tethers is increased as desired by successive carboimide 
reactions at a nanotubule (n) entrance. Polypeptide tether 
length is controlled by the number of times the terminal 
carboxylate on the nanotubule (n) is activated by EDC 
coupling agent, folloWed by placement in 8-amino caprylic 
acid (ACA) solution. Charged molecules such as those 
depicted in FIGS. 7a-c are coupled to the polypeptide tethers 
using the same carboimide chemistry as previously 
described. 
EXAMPLE 10 
Referring to FIG. 7d, a charged molecule is attached to a 
nanotubule pore carboxylate group by addition of a thiol 
(SH) group, folloWed by covalent bonding to a gold nanoc 
rystal. Gold nanocrystals are normally anionically charged 
to be a stable colloidal system, and therefore the molecule’s 
position at the nanotubule pore entrance can be altered from 
an occluding position to an open position by electrostatic 
force. 
5 
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The foregoing description of the preferred embodiment of 
this invention has been presented for purposes of illustration 
and description. It is not intended to be exhaustive or to limit 
the invention to the precise form disclosed. Obvious modi 
?cations or variations are possible in light of the above 
teachings. For example, the method of providing an aligned 
array of holloW nanotubules is not limited to the example 
described in Example 1. Any suitable method for providing 
an aligned array of nanotubules may be employed, such as 
for example embedding nanotubules such as carbon nano 
tubes in a porous alumina template. It is also knoWn to groW 
carbon nanotubes or other self-assembling nanotubules in 
situ in a porous template such as alumina. 
Similarly, the additional functional group may be bound 
adjacent the nanotubule pore of the ordered nanoporous 
membrane by alternative methods, With the proviso that the 
functional groups bind only near the nanotubule tips, rather 
than binding further into the interior of the nanotubule 
lumen. For example, it is knoWn to electrochemically 
modify graphitic surfaces to alloW binding of functional 
groups. Saby et al. demonstrated electrochemical reduction 
of substituted (using a para substituent such as nitro, car 
boxy, etc.) phenyl diaZonium to form a diaZonium radical, 
covalently binding to the surface of a glassy carbon elec 
trode, and grafting a correspondingly substituted phenyl 
group [see Saby et al., Electrochemical Modi?cation of 
Glassy Carbon Electrode Using Aromatic DiaZonium Salts. 
l. Blocking Effect of 4-Nitrophenyl and 4-Carboxyphenyl 
Groups, Langmuir 13, p. 6805-6813 (1997)]. 
MarWan et al. demonstrated electrochemical grafting of 
N,N-Diethylaniline to a glassy carbon electrode, folloWed 
by binding a charged copper molecule or Prussian Blue dye, 
as Well as modi?cation of a glassy carbon electrode With 
4-sulfonate phenyl and binding of charged ruthenium [Mar 
Wan et al., FunctionaliZation of glassy carbon electrodes 
With metal-based species, Chem. Mater. 17, pp. 2395-2403 
(2005)]. It Will be appreciated that, for example, the ordered 
nanoporous membranes of the present invention comprising 
carbon nanotubes could be similarly modi?ed to bind func 
tional groups. Because only the tips of the carbon nanotubes 
extend beyond the surface of the matrix in Which they are 
embedded, functional groups Would bind only to the nano 
tube tips, and therefore only adjacent the membrane pores. 
The embodiment Was chosen and described to provide the 
best illustration of the principles of the invention and its 
practical application to thereby enable one of ordinary skill 
in the art to utiliZe the invention in various embodiments and 
With various modi?cations as are suited to the particular use 
contemplated. All such modi?cations and variations are 
Within the scope of the invention as determined by the 
appended claims When interpreted in accordance With the 
breadth to Which they are fairly, legally, and equitably 
entitled. 
What is claimed is: 
1. A device for cutaneous delivery of a composition, 
comprising: 
an ordered nanoporous membrane including a plurality of 
aligned holloW nanotubules held in a continuous poly 
mer matrix, the plurality of aligned holloW nanotubules 
having a lumen de?ning at least one pore passing 
through the ordered nanoporous membrane; and 
a reservoir for holding the composition, said reservoir in 
?uid communication With the ordered nanoporous 
membrane. 
2. The device of claim 1, Wherein the ordered nanoporous 
membrane includes at least one functional unit bound adja 
cent to the pore. 
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3. The device of claim 2, wherein the at least one 
functional unit selectively exposes or at least partially 
occludes the pore of an adjacent nanotubule. 
4. The device of claim 3, Wherein the at least one 
functional unit is selected from the group consisting of a 
ligand, a receptor, a receptor-ligand complex, a reversibly 
binding receptor-ligand complex, a charged molecule, a 
binder-ligand complex, a reversibly binding binder-ligand 
complex, a ligand adapted for speci?cally binding to a 
predetermined target molecule, a hydrophilic molecule, a 
hydrophobic molecule, a catalytic coordination compound, a 
catalytic metal, biotin, avidin, streptavidin, aliphatic amines, 
charged dyes, anionically charged ligands, cationically 
charged ligands, and any combination thereof. 
5. The device of claim 3, Wherein the at least one 
functional unit is selectively displaceable to at least partially 
expose or at least partially occlude the pore of an adjacent 
nanotubule. 
6. The device of claim 5, Wherein the at least one 
functional unit includes a charged group. 
7. The device of claim 6, Wherein the at least one 
functional unit is selected from the group of charged groups 
consisting of acetate, aluminate, amino sulfonate, ammo 
nium, quaternary ammonium, arsenate, aZide, carbonate, 
borate, bromate, bromite, carbide, chlorite, chromate, 
chromite, cyanate, dichromate, phosphate, phosphite, disul 
?de, formate, fulminate, sulfate, sul?de, hydrogen sul?te, 
hydroxide, nitrate, nitrite, oxalate, pyridinium, pyrophos 
phate, sul?te, sulfonium, tartrate, thiocyanate, thiosulfate, 
toluenesulfonate, charged metal coordination compounds, 
and any combination thereof. 
8. The device of claim 6, Wherein the continuous polymer 
matrix is electrically insulating. 
9. The device of claim 6, Wherein the aligned holloW 
nanotubules are electrically conductive. 
10. The device of claim 5, further including at least one 
contact in electrical communication With the ordered nan 
oporous membrane. 
11. The device of claim 10, further including an actuator 
in electrical communication With the at least one contact. 
12. The device of claim 1, Wherein the nanotubules are 
selected from the group consisting of multi-Walled carbon 
nanotubes, single-Walled carbon nanotubes, self-assembling 
macromolecular tubules comprising peptides and porphy 
rins, and any combination thereof. 
13. The device of claim 1, further including a fastener for 
holding the device adjacent to a surface. 
14. The device of claim 13, Wherein the fastener is 
selected from the group consisting of an adhesive, a pressure 
sensitive adhesive, an elastic band, loop, or ring, a hook and 
loop material, a tape, a strap securable by adhesive, hook 
and loop material, or a buckle, a tie, and any combination 
thereof. 
15. A method for cutaneous delivery of a composition, 
comprising: 
providing a reservoir containing the composition in ?uid 
communication With an ordered nanoporous membrane 
comprising a plurality of holloW nanotubules held in a 
continuous polymer matrix, the plurality of holloW 
nanotubules having a lumen de?ning at least one pore 
passing through the ordered nanoporous membrane; 
and 
passing the composition through the ordered nanoporous 
membrane. 
16. The method of claim 15, Wherein the ordered nan 
oporous membrane is formed by aligning the plurality of 
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holloW nanotubules, coating the aligned holloW nanotubules 
With the continuous polymer matrix to form a membrane, 
and etching the membrane to open the plurality of holloW 
nanotubules and form pores. 
17. The method of claim 16, further including the step of 
binding at least one functional unit adjacent to the nanotu 
bule pore. 
18. The method of claim 17, Wherein the at least one 
functional unit selectively exposes or at least partially 
occludes the pore of an adjacent nanotubule. 
19. The method of claim 18, including selecting the at 
least one functional unit from the group consisting of a 
ligand, a receptor, a receptor-ligand complex, a reversibly 
binding receptor-ligand complex, a charged molecule, a 
binder-ligand complex, a reversibly binding binder-ligand 
complex, a ligand adapted for speci?cally binding to a 
predetermined target molecule, a hydrophilic molecule, a 
hydrophobic molecule, a catalytic coordination compound, a 
catalytic metal, biotin, avidin, streptavidin, aliphatic amines, 
charged dyes, anionically charged ligands, cationically 
charged ligands, and any combination thereof. 
20. The method of claim 18, Wherein the functional unit 
is selectively displaceable to at least partially expose or at 
least partially occlude the pore of an adjacent nanotubule. 
21. The method of claim 20, including selecting a func 
tional unit having a charged group. 
22. The method of claim 21, including selecting the at 
least one functional unit from the group consisting of 
acetate, aluminate, amino sulfonate, ammonium, quaternary 
ammonium, arsenate, aZide, carbonate, borate, bromate, 
bromite, carbide, chlorite, chromate, chromite, cyanate, 
dichromate, phosphate, phosphite, disul?de, formate, fulmi 
nate, sulfate, sul?de, hydrogen sul?te, hydroxide, nitrate, 
nitrite, oxalate, pyridinium, pyrophosphate, sul?te, sulfo 
nium, tartrate, thiocyanate, thiosulfate, toluenesulfonate, 
charged metal coordination compounds, and any combina 
tion thereof. 
23. The method of claim 21, further including the step of 
providing at least one contact in electrical communication 
With the ordered nanoporous membrane. 
24. The method of claim 23, further including the step of 
providing an actuator in electrical communication With the 
at least one contact. 
25. The method of claim 21, Wherein the plurality of 
aligned holloW nanotubules are electrically conductive. 
26. The method of claim 21, Wherein the continuous 
polymer matrix is formed of an electrically insulating poly 
mer. 
27. The method of claim 16, further including the step of 
providing a fastener for holding the ordered nanoporous 
membrane adjacent to a surface. 
28. A device for cutaneous delivery of a composition, 
comprising: 
an ordered nanoporous membrane including a plurality of 
aligned holloW nanotubules held in a continuous poly 
mer matrix; and 
a reservoir for holding the composition, said reservoir in 
?uid communication With the ordered nanoporous 
membrane; 
Wherein the ordered nanoporous membrane further 
includes at least one functional unit bound adjacent to 
a pore de?ned by a lumen of the holloW nanotubule. 
* * * * * 
